Capital Research Global Investors, a registered investment adviser, initiated a new position in Eli Lilly and Company (NYSE:LLY) during Q4 2025, according to its most recent 13F…
Capital Research Global Investors, a registered investment adviser, initiated a new position in Eli Lilly and Company (NYSE:LLY) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 24,566,846 shares of the Healthcare company, valued at approximately $26.4B as of the filing date.
Eli Lilly and Company's stock currently trades at $1015.21 with a market capitalization of $906.5B.
Current market data
NYSE · LLY
$1,152.93
Down: -$0.22 · -0.02%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
institutional ·
institutional ·
price ·
price ·
